FDA Approves Treatment for Rare Genetic Disease
The U.S. Food and Drug Administration recently approved Xenpozyme (Olipudase alfa) for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD), a rare genetic disease that causes …
FDA Approves Treatment for Rare Genetic Disease Read More